Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
2017 ◽
Vol 7
(4)
◽
pp. 271-277
2017 ◽
Vol 21
(2 (82) p.1)
◽
pp. 71-75